Drug giants' merger collapse set to hit shares
The two pharmaceutical giants represent about 8% of the FT-SE 100 and have been responsible for a 15% rise in the index since the merger was announced on 30 January. Their planned get-together gave confidence to merger speculation in the financial sector to push blue-chips shares to a record ...
Keep reading this article by becoming a FlightGlobal member now
PLEASE REGISTER FOR FREE OR SIGN IN TO CONTINUE READING
You have reached your limit of free articles for this period. Register for a FREE account to read this article and benefit from:
- Increased access to online news and in-depth articles from:
- FlightGlobal Premium covering the global aviation industry
- Airline Business providing insight for business leaders
- Weekly newsletters on topics across the industry
From making its debut as a magazine in 1985 through to its evolution into an online data and analysis tool, Airline Business has forged a reputation for providing high-quality, in-depth coverage of the airline sector’s strategic and economic drivers. Our trusted insight gives users a competitive edge in the global industry.